Drug and Alcohol Dependence response to KK-21-1460 "Considering rationales for use in defining subgroups for the treatment of stimulant use disorder"

Drug Alcohol Depend. 2021 Apr 1:221:108571. doi: 10.1016/j.drugalcdep.2021.108571. Epub 2021 Feb 4.

Authors

Brian Chan¹, Michele Freeman², Chelsea Ayers², P Korthuis², Robin Paynter², Karli Kondo², Devan Kansagara²

Affiliations

¹ Division of General Internal Medicine, Section of Addiction Medicine, Oregon Health & Science University, 3181 SW Sam Jackson Park Road L475, Portland, OR 97239-3098, United States. Electronic address: chanbri@ohsu.edu.
² Division of General Internal Medicine, Section of Addiction Medicine, Oregon Health & Science University, 3181 SW Sam Jackson Park Road L475, Portland, OR 97239-3098, United States.

PMID: 33597113
DOI: 10.1016/j.drugalcdep.2021.108571

No abstract available

Publication types

Letter
Comment

MeSH terms

Alcoholism* / drug therapy
Central Nervous System Stimulants* / adverse effects
Humans
Opioid-Related Disorders* / drug therapy
Pharmaceutical Preparations*
Substance-Related Disorders* / drug therapy

Substances

Central Nervous System Stimulants
Pharmaceutical Preparations